Description

Description:
Semaglutide 20 mg is a high-purity synthetic analog of glucagon-like peptide-1 (GLP-1), designed for advanced metabolic and endocrine research. This extended-dose formulation provides additional material for studies requiring larger-scale or long-term assays of peptide stability, GLP-1 receptor activity, and glucose-homeostasis modeling. Structural substitutions enhance resistance to enzymatic degradation, prolonging half-life and bioavailability under controlled experimental conditions.

Research Applications:
Semaglutide 20 mg is utilized in preclinical and in vitro investigations focused on:

• GLP-1 receptor binding, activation, and signaling kinetics
• Peptide-driven insulin-secretion and glucose-regulation mechanisms
• Comparative pharmacodynamic profiling of GLP-1 analogs
• Studies of molecular stability, solubility, and peptide optimization

Molecular Formula: C₁₈₇H₂₉₁N₄₅O₅₉
Molecular Weight: ≈ 4113.58 g/mol
Sequence: H-Aib-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-Lys-Glu-Phe-Ile-Ala-Trp-Leu-Val-Arg-Gly-Arg-NH₂

Form: Lyophilized powder
Purity: ≥ 98 % (HPLC)
Storage: Store at –20 °C. Avoid repeated freeze-thaw cycles.
Solubility: Soluble in sterile water or aqueous buffer

Handling and Use:
This material is supplied strictly for in vitro laboratory research. It is not for human consumption, veterinary use, or diagnostic applications. Follow appropriate protective laboratory protocols and aseptic procedures when handling all research compounds.